Skip to content

Neurology and Cognitive Vitality: Strategies for Lifelong Brain Health

Thursday, September 25th, 2025 | Breakout Room 4


When the Brain Sends Subtle Signals, Advanced Testing Reveals the Truth 

Cognitive decline doesn’t start with memory loss. It begins with silent immune dysregulation, blood-brain barrier (BBB) permeability, and mitochondrial imbalance. By the time neuroimaging reveals changes, decades of neuroinflammatory damage may already be in motion.

This track equips you to identify those early warning signs using antibody panels, genetic data, and oxidative stress markers, allowing you to intervene long before symptoms become irreversible.

Neural-Track

The Invisible Onset of Brain Aging

Standard labs often miss the earliest signs of neurological decline. Patients with fatigue, brain fog, anxiety, or post-viral syndromes are often dismissed, despite mounting neuroimmune dysfunction.

This session gives you the tools to detect subtle shifts in brain health using Vibrant’s Neural Zoomer Plus, Blood-Brain Barrier Panel, ApoE and MTHFR genotyping, and methylation-focused testing. You’ll learn how to create protocols that reinforce brain resilience, modulate neuroinflammation, and prevent neurodegeneration.

Key Learning Objectives

Cognitive vitality is supported by a clear understanding of the molecular and immune drivers of neurodegeneration. This track helps you apply that science in a clinically actionable way.

  • Catch decline early, before imaging does: Use markers like antibodies to myelin basic protein, S100B, alpha-synuclein, and anti-GAD65 to detect early neuroautoimmunity and permeability-related dysfunction.
  • Genetically stratify your patients: Understand how genetic risk factors like ApoE4 and MTHFR mutations contribute to mitochondrial stress, homocysteine elevation, and impaired detoxification.
  • Balance neurotransmitters and redox pathways: Use methylation and neurotransmitter panels to assess the brain’s biochemical environment, and create personalized support strategies using neurotrophic, antioxidant, and adaptogenic compounds.
  • Create structured programs for brain health: Bundle key panels and develop protocols around phased support—methylation first, inflammation second, neurotransmission third—tailored to biomarker patterns and genetic vulnerabilities.

Walk away with protocols, patient communication strategies, and business-ready brain longevity offerings that integrate seamlessly into functional care models.

Clinical Snapshot

When Antibodies Told the Real Story

Patient: 47-year-old female executive with anxiety, brain fog, and recent post-viral fatigue

History: Normal MRI, no psychiatric diagnosis, failed SSRI and adaptogen protocols

Findings:

  • Positive antibodies to S100B and myelin basic protein (Neural Zoomer Plus)
  • ApoE4 heterozygous, elevated homocysteine
  • Low SAM/SAH ratio, low glutathione
  • Dopamine and GABA imbalance on neurotransmitter testing

Protocol:

  • 4-week phase of BBB repair and methylation support
  • 8-week neuroimmune modulation with antioxidants, NAC, and omega-3s
  • Neurotransmitter balancing and lifestyle modifications including vagus nerve activation

Outcome: Improved cognition, stabilized mood, and reduced neuroimmune markers by 3-month retest.

Conventional Brain Care vs. Cognitive Longevity Protocols

Most neurological care begins after symptoms appear. Precision protocols track immune, oxidative, and neurotransmitter changes early to protect long-term brain function.

Focus

Detection

Protocol Design

Patient Engagement

Clinical Impact

Conventional Neurology

Imaging and symptomatic care

Late-stage diagnosis

Medication or “wait and see”

Reactive, fragmented

Disease management

Cognitive Longevity Protocols

Immune biomarkers, permeability, methylation

Early antibody, oxidative, and neurotransmitter shifts

Targeted, phased, test-driven

Personalized, prevention-focused

Brain resilience and long-term performance

Who This Track Is For

Brain FogProviders treating cognitive fog, anxiety, burnout, or early-stage decline

Frustrated-ProviderClinicians frustrated by "normal" neuroimaging that doesn’t match symptoms

Revenue-ProgramPractices building brain longevity, neurorecovery, or nootropic optimization offerings

BrainAnyone ready to support the brain with the same precision used for hormones and metabolism

Make Brain Health Your Differentiator

Cognitive function is a top priority for high-performing and longevity-focused patients. This session shows you how to be a leader in brain health by offering structured programs that begin where traditional approaches fall short.

You'll learn how to:

  • Interpret neural autoantibodies and BBB markers in early-stage decline
  • Personalize cognitive protocols with genetic, redox, and neurotransmitter data
  • Create bundled brain longevity offerings that support mood, memory, and neuroprotection
  • Build prevention and recovery programs that resonate with peak performers and those recovering from stress or illness
Whether you’re working with burned-out professionals, post-viral patients, or early-cognitive-decline cases, this track offers the clinical tools and patient frameworks you need.

Speaker Lineup

Dr. Eboni Cornish

Dr. Eboni Cornish, MD

Learning Track Speaker
Dr. Victor Carsrud

Dr. Victor Carsrud, PhD, MD, DC, MBBS, MS, MS, DABCI, DCBCN

Learning Track Speaker
Dr. Neela Sandal, MD

Dr. Neela Sandal, MD

Learning Track Speaker
Dr. Chad Prusmack

Dr. Chad Prusmack, MD

Learning Track Speaker
Longevity-Summit-Logo-Std

Interested in locking in your spot at Neurology and Cognitive Vitality: Strategies for Lifelong Brain Health?

Be sure to sign up for this learning track at registration when you arrive at The Vibrant Longevity Summit.